Inflammatory Disease Research Centre, Department of Redox Mediated Diseases and Therapeutics, 4371Northlake Blvd #247, Palm Beach Gardens, Florida 33410, USA
Case Report
Sustained Histologic Remission (Complete Mucosal Healing) 12 Years after One-Time Treatment of Refractory Ulcerative Colitis with Novel Combination Therapy: A Case Report
Author(s): Jay Pravda*, Richard Gordon and Pamela B. Sylvestre
Ulcerative colitis is a major form of chronic inflammatory bowel disease affecting millions of individuals worldwide. It most often strikes in the prime of life, during late adolescence and early adulthood. Individuals with ulcerative colitis experience life-long reoccurring and unpredictable episodes of abdominal pain and bloody diarrhea lasting from weeks to months. This results in significant emotional and psychological burdens leading to life-long disruption of daily activities and quality of life. Environmental factors acting in concert with genetic, epigenetic, and microbiome influences are thought to trigger an immune abnormality leading to the chronic colonic inflammation observed in this condition. However, despite extensive research, a primary antecedent immune vulnerability has not been demonstrated in patients or healthy family members. Current therapy is primarily focused.. Read More»
DOI:
10.37421/2476-1958.2020.5.132
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 